| A consensus molecular classification of muscle-invasive bladder cancer A Kamoun, A de Reyniès, Y Allory, G Sjödahl, AG Robertson, R Seiler, ... European urology 77 (4), 420-433, 2020 | 931 | 2020 |
| The oestrogen receptor alpha-regulated lncRNA NEAT1 is a critical modulator of prostate cancer D Chakravarty, A Sboner, SS Nair, E Giannopoulou, R Li, S Hennig, ... Nature communications 5 (1), 5383, 2014 | 591 | 2014 |
| Whole-exome sequencing of metastatic cancer and biomarkers of treatment response H Beltran, K Eng, JM Mosquera, A Sigaras, A Romanel, H Rennert, ... JAMA oncology 1 (4), 466-474, 2015 | 306 | 2015 |
| PD-L1 expression in perihilar and intrahepatic cholangiocarcinoma J Fontugne, J Augustin, A Pujals, P Compagnon, B Rousseau, A Luciani, ... Oncotarget 8 (15), 24644, 2017 | 163 | 2017 |
| ERG induces taxane resistance in castration-resistant prostate cancer G Galletti, A Matov, H Beltran, J Fontugne, J Miguel Mosquera, C Cheung, ... Nature communications 5 (1), 5548, 2014 | 126 | 2014 |
| Prognostic biomarkers used for localised prostate cancer management: a systematic review PJ Lamy, Y Allory, AS Gauchez, B Asselain, P Beuzeboc, P De Cremoux, ... European Urology Focus 4 (6), 790-803, 2018 | 104 | 2018 |
| Unraveling the clonal hierarchy of somatic genomic aberrations D Prandi, SC Baca, A Romanel, CE Barbieri, JM Mosquera, J Fontugne, ... Genome biology 15, 1-16, 2014 | 104 | 2014 |
| Tertiary lymphoid structures marker CXCL13 is associated with better survival for patients with advanced-stage bladder cancer treated with immunotherapy CS Groeneveld, J Fontugne, L Cabel, I Bernard-Pierrot, F Radvanyi, ... European Journal of Cancer 148, 181-189, 2021 | 85 | 2021 |
| Next-generation rapid autopsies enable tumor evolution tracking and generation of preclinical models DJ Pisapia, S Salvatore, C Pauli, E Hissong, K Eng, D Prandi, VW Sailer, ... JCO precision oncology 1, 1-13, 2017 | 52 | 2017 |
| Identification of new driver and passenger mutations within APOBEC-induced hotspot mutations in bladder cancer MJ Shi, XY Meng, J Fontugne, CL Chen, F Radvanyi, I Bernard-Pierrot Genome medicine 12, 1-20, 2020 | 46 | 2020 |
| Integrative multiplatform molecular profiling of benign prostatic hyperplasia identifies distinct subtypes D Liu, JE Shoag, D Poliak, RS Goueli, V Ravikumar, D Redmond, ... Nature communications 11 (1), 1987, 2020 | 40 | 2020 |
| Integrative molecular analysis of patients with advanced and metastatic cancer V Sailer, KW Eng, T Zhang, R Bareja, DJ Pisapia, A Sigaras, B Bhinder, ... JCO precision oncology 3, 1-12, 2019 | 39 | 2019 |
| Recurrent prostate cancer genomic alterations predict response to brachytherapy treatment J Fontugne, D Lee, C Cantaloni, CE Barbieri, O Caffo, E Hanspeter, ... Cancer epidemiology, biomarkers & prevention 23 (4), 594-600, 2014 | 32 | 2014 |
| Clonal evaluation of prostate cancer foci in biopsies with discontinuous tumor involvement by dual ERG/SPINK1 immunohistochemistry J Fontugne, K Davis, N Palanisamy, A Udager, R Mehra, AS McDaniel, ... Modern Pathology 29 (2), 157-165, 2016 | 29 | 2016 |
| Multicenter validation of histopathologic tumor regression grade after neoadjuvant chemotherapy in muscle-invasive bladder carcinoma CS Voskuilen, HZ Oo, V Genitsch, LA Smit, A Vidal, M Meneses, A Necchi, ... The American journal of surgical pathology 43 (12), 1600-1610, 2019 | 23 | 2019 |
| Molecular alterations in prostate cancer and association with MRI features D Lee, J Fontugne, N Gumpeni, K Park, TY MacDonald, BD Robinson, ... Prostate cancer and prostatic diseases 20 (4), 430-435, 2017 | 22 | 2017 |
| Cold‐associated perniosis of the thighs histopathologically mimicking lupus. Six observations R Karkouche, C Bernigaud, J Fontugne, O Zehou, G Bellaud, M N'Diaye, ... Journal of the European Academy of Dermatology and Venereology 31 (6), 1029-1032, 2017 | 17 | 2017 |
| HPV RNA CISH score identifies two prognostic groups in a p16 positive oropharyngeal squamous cell carcinoma population J Augustin, M Mandavit, S Outh-Gauer, O Grard, C Gasne, C Lépine, ... Modern Pathology 31 (11), 1645-1652, 2018 | 16 | 2018 |
| FGFR3 mutational activation can induce luminal-like papillary bladder tumor formation and favors a male sex bias MJ Shi, J Fontugne, A Moreno-Vega, XY Meng, C Groeneveld, F Dufour, ... European Urology 83 (1), 70-81, 2023 | 10 | 2023 |
| Collision tumors revealed by prospectively assessing subtype-defining molecular alterations in 904 individual prostate cancer foci J Fontugne, PY Cai, H Alnajar, B Bhinder, K Park, H Ye, S Beg, V Sailer, ... JCI insight 7 (4), 2022 | 8 | 2022 |
